Vertex Pharmaceuticals
VRTX
#177
Rank
โ‚น10.589 T
Marketcap
โ‚น41,304
Share price
0.90%
Change (1 day)
19.98%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): โ‚น386.38 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are โ‚น11.72 Billion. In 2024 the company made an earning of โ‚น25.04 Billion a decrease over its 2023 earnings that were of โ‚น396.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น386.38 B1442.85%
2024 โ‚น25.04 B-93.69%
2023 โ‚น396.95 B3.19%
2022 โ‚น384.69 B53.56%
2021 โ‚น250.52 B-12.06%
2020 โ‚น284.88 B118.45%
2019 โ‚น130.41 B120.64%
2018 โ‚น59.10 B1473.64%
2017 โ‚น3.75 B197.6%
2016 โ‚น1.26 B-102.97%
2015 -โ‚น42.5 Billion-28.46%
2014 -โ‚น59.41 Billion-51.5%
2013 -โ‚น122.5 Billion-30584.68%
2012 โ‚น0.40 B-95.47%
2011 โ‚น8.87 B
2009 -โ‚น53.2 Billion
2007 -โ‚น37.03 Billion83.1%
2006 -โ‚น20.23 Billion59.02%
2005 -โ‚น12.72 Billion3.28%
2004 -โ‚น12.32 Billion-38.16%
2003 -โ‚น19.92 Billion
2000 -โ‚น3.42 Billion-20.38%
1999 -โ‚น4.29 Billion31.62%
1998 -โ‚น3.26 Billion91.05%
1997 -โ‚น1.71 Billion-36.24%
1996 -โ‚น2.68 Billion12.45%
1995 -โ‚น2.38 Billion27.4%
1994 -โ‚น1.87 Billion-1833.33%
1993 โ‚น0.10 B-112.12%
1992 -โ‚น0.89 Billion175%
1991 -โ‚น0.33 Billion-12.2%
1990 -โ‚น0.37 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น887.07 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น148.95 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.071 T 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น720.80 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.906 T 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-โ‚น6.81 Billion-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA